Dr. Eric Christopher Wilkerson, MD

Dr. Wilkerson practices at Fort Lauderdale Dermatology in Fort Lauderdale, Florida.

Dr. Wilkerson's NPI, 1841556396, was assigned on April 10, 2012. Dr. Wilkerson graduated from University Of Louisville School Of Medicine in 2012. Dr. Wilkerson holds Florida license ME134777.

Dr. Wilkerson's primary practice is Fort Lauderdale Dermatology, at 2021 E Commercial Blvd Suite 301 Suite 301, Fort Lauderdale, FL 33308-3754. The practice phone is (954) 546-3376.

Dr. Wilkerson's primary practice is Fort Lauderdale Dermatology in Fort Lauderdale, Florida. The medical group on file is Fort Lauderdale Dermatology.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wilkerson practices. Vendor and product names are available with a free account.

Dermatology is Dr. Wilkerson's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Wilkerson is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Wilkerson's licenses on file in 4 states: Florida, Ohio, New York and New Jersey.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, facial skin infection and itchy rashes among the conditions Dr. Wilkerson treats.

CMS data shows 4,304 Medicare services from Dr. Wilkerson across 27 procedure codes in 2024, for 589 Medicare patients. Medicare paid $262,413 for them. Every service was in an office.

CMS counts 589 Medicare patients who saw Dr. Wilkerson in 2024. The largest group is 65 to 74, with 268 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 2% are also on Medicaid. Their average risk score is 1.02, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Wilkerson's median patient age at 70, with 44% women.

In 2024, Dr. Wilkerson wrote 1,118 Medicare Part D claims for 408 patients. 98% of them were for generic drugs. CMS names the drug for 970 of them, across 17 drugs with 11 or more claims each, at $22,008 in total drug cost. In 2023, CMS named 828 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Wilkerson for performance year 2024, reported individually. Dr. Wilkerson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 474 procedures of skin biopsy by Dr. Wilkerson, more than 95% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 10 papers to Dr. Wilkerson, published from 2013 to 2020. 2020 was the busiest year, with 2. The most frequent topics are Mohs Surgery, Skin and Skin Neoplasms. Dr. Wilkerson has published most often in Dermatol Surg. Dr. Wilkerson's most frequent co-authors are Bradley Stephen Bloom, MD, Brian R. Gastman, MD and Soon Bahrami, MD.

CMS Open Payments shows 36 general payments to Dr. Wilkerson from 15 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Galderma Laboratories, L.P. paid the most, $375.

Dr. Wilkerson graduated from University Of Louisville School Of Medicine in 2012.

Dr. Wilkerson is in network with 16 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.